Microarray experiments performed in sural nerve biopsy samples have a uncovered a unique gene signature that characterizes progressing diabetic neuropathy. The study, published in Brain, identifed 532 genes that were differentially expressed between patients with progressing and non-progressing diabetic neuropathy. The investigators developed a computational model that incorporated 14 of these genes and could accurately classify the progression status in 92% of cases.